ensaculin has been researched along with om99-2 in 1 studies
| Studies (ensaculin) | Trials (ensaculin) | Recent Studies (post-2010) (ensaculin) | Studies (om99-2) | Trials (om99-2) | Recent Studies (post-2010) (om99-2) |
|---|---|---|---|---|---|
| 12 | 1 | 1 | 57 | 0 | 25 |
| Protein | Taxonomy | ensaculin (IC50) | om99-2 (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.014 | |
| Cathepsin D | Homo sapiens (human) | 0.0042 | |
| Beta-secretase 1 | Homo sapiens (human) | 0.0263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amini, M; Edraki, N; Khan, MI; Mahdavi, M; Moghadam, FH; Nadri, H; Saeedi, M; Sameem, B | 1 |
1 other study(ies) available for ensaculin and om99-2
| Article | Year |
|---|---|
Synthesis, docking study and neuroprotective effects of some novel pyrano[3,2-c]chromene derivatives bearing morpholine/phenylpiperazine moiety.
Topics: Animals; Apoptosis; Benzopyrans; Cholinesterase Inhibitors; Molecular Docking Simulation; Morpholines; Neuroprotective Agents; PC12 Cells; Piperazines; Rats | 2017 |